Centene Corp

CNC

Equity

ISIN null / Valor 1313733

New York Stock Exchange, Inc (2025-10-17)

USD 35.27-1.04%

Centene Corp
UMushroom community rating:

4.80 5 votes No rating yet

NegativeNeutralPositive

About company

Centene Corp is a leading provider of affordable and high-quality healthcare products, serving a significant portion of the population through government-sponsored programs such as Medicaid, Medicare, the Health Insurance Marketplace, and the TRICARE program. With over 30 years of experience, Centene focuses on saving costs and enhancing medical outcomes for its stakeholders, including state governments, healthcare providers, and individuals and families. The company emphasizes collaboration to ensure access to quality care for every person, recognizing the unique needs of each state, individual, and family.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Growth

Centene's premium and service revenues surged by 18% to $42.5 billion in Q2 2025, driven primarily by significant growth in the Medicare Prescription Drug Plan (PDP) business and the Marketplace segment, alongside rate increases in Medicaid.

Improved SG&A Expense Ratio

The Selling, General, and Administrative (SG&A) expense ratio decreased to 7.1% in Q2 2025 from 8.0% in the second quarter of 2024. This improvement was attributed to higher revenues and the expansion of the PDP business, partially offset by increased expenses in the Marketplace segment.

Membership Expansion

Total at-risk membership rose to 28.0 million in Q2 2025, up from 25.7 million in the same quarter the previous year. Notable growth was seen in the Medicare segment, which saw a 58% increase in premium and service revenues to $9.45 billion.

Summarized from source with an LLMView Source

Key figures

-44.0%1Y

-53.1%3Y

-46.7%5Y

Performance

66.3%1Y

44.2%3Y

39.8%5Y

Volatility